<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
VCNX
Vaccinex
$
()


  • Vaccinex reports Q1 EPS ($2.94) vs. ($20.89) last year

    5/15/2024 - 18:02pm
  • Vaccinex files to sell 193,000 shares of common stock for holders

    4/26/2024 - 17:19pm
  • Vaccinex files to sell 434K shares of common stock for holders

    4/2/2024 - 16:13pm
  • Vaccinex reports FY23 EPS ($43.68) vs ($98.05) last year

    4/2/2024 - 08:41am
  • Vaccinex prices 193,000 shares at $7.77 in registered direct offering

    3/27/2024 - 08:36am
  • Biotech Alert: Searches spiking for these stocks today

    2/22/2024 - 10:59am
  • Vaccinex enters eight new antibody discovery agreements for use of ActivMAb

    2/21/2024 - 08:07am
  • Vaccinex trading halted, news pending

    2/16/2024 - 19:50pm
  • Vaccinex announces 1-for-14 reverse stock split

    2/15/2024 - 08:04am
  • Vaccinex prices 3.84M shares at 72.5c in private placement

    2/7/2024 - 08:10am
  • Vaccinex files to sell 712,484 shares of common stock for holders

    1/10/2024 - 17:18pm
  • Vaccinex announces Nasdaq granted vaccine extension until March 4, 2024

    12/4/2023 - 08:16am
  • Vaccinex reports Q3 EPS ($1.09) vs. ($1.67) last year

    11/13/2023 - 08:06am
  • Vaccinex reports clinical benefit in interim analyses from Phase 2 studies

    10/31/2023 - 09:05am
  • Vaccinex announces presentation of findings for pepinemab

    10/26/2023 - 09:34am
dynamic_feed Breaking News